238 related articles for article (PubMed ID: 1612952)
1. Radiation therapy for diabetes insipidus caused by Langerhans cell histiocytosis.
Minehan KJ; Chen MG; Zimmerman D; Su JQ; Colby TV; Shaw EG
Int J Radiat Oncol Biol Phys; 1992; 23(3):519-24. PubMed ID: 1612952
[TBL] [Abstract][Full Text] [Related]
2. Diabetes insipidus secondary to Langerhans' cell histiocytosis: is radiation therapy indicated?
Rosenzweig KE; Arceci RJ; Tarbell NJ
Med Pediatr Oncol; 1997 Jul; 29(1):36-40. PubMed ID: 9142204
[TBL] [Abstract][Full Text] [Related]
3. MR of the hypothalamic-pituitary axis in Langerhans cell histiocytosis.
Maghnie M; Aricò M; Villa A; Genovese E; Beluffi G; Severi F
AJNR Am J Neuroradiol; 1992; 13(5):1365-71. PubMed ID: 1414829
[TBL] [Abstract][Full Text] [Related]
4. The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis.
Dunger DB; Broadbent V; Yeoman E; Seckl JR; Lightman SL; Grant DB; Pritchard J
N Engl J Med; 1989 Oct; 321(17):1157-62. PubMed ID: 2797079
[TBL] [Abstract][Full Text] [Related]
5. Hypothalamo-pituitary abnormalities in adult patients with langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment.
Kaltsas GA; Powles TB; Evanson J; Plowman PN; Drinkwater JE; Jenkins PJ; Monson JP; Besser GM; Grossman AB
J Clin Endocrinol Metab; 2000 Apr; 85(4):1370-6. PubMed ID: 10770168
[TBL] [Abstract][Full Text] [Related]
6. Radiation therapy in soft-tissue lesions in histiocytosis X (Langerhans' cell histiocytosis).
Gramatovici R; D'Angio GJ
Med Pediatr Oncol; 1988; 16(4):259-62. PubMed ID: 3262194
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of radiation therapy in the management of Langerhans cell histiocytosis.
Kotecha R; Venkatramani R; Jubran RF; Arkader A; Olch AJ; Wong K
Am J Clin Oncol; 2014 Dec; 37(6):592-6. PubMed ID: 23466581
[TBL] [Abstract][Full Text] [Related]
8. Diabetes insipidus associated with Langerhans cell histiocytosis: is it reversible?
Broadbent V; Pritchard J
Med Pediatr Oncol; 1997 Apr; 28(4):289-93. PubMed ID: 9078326
[TBL] [Abstract][Full Text] [Related]
9. Growth and endocrine disorders in multisystem Langerhans' cell histiocytosis.
Nanduri VR; Bareille P; Pritchard J; Stanhope R
Clin Endocrinol (Oxf); 2000 Oct; 53(4):509-15. PubMed ID: 11012577
[TBL] [Abstract][Full Text] [Related]
10. Anterior pituitary function and computed tomography/magnetic resonance imaging in patients with Langerhans cell histiocytosis and diabetes insipidus.
Broadbent V; Dunger DB; Yeomans E; Kendall B
Med Pediatr Oncol; 1993; 21(9):649-54. PubMed ID: 8412998
[TBL] [Abstract][Full Text] [Related]
11. [Central diabetes insipidus in adult patients--the first sign of Langerhans cell histiocytosis and Erdheim-Chester disease. Three case studies and literature review].
Adam Z; Balsíková K; Krejcí M; Pour L; Stĕpánková S; Svacina P; Hermanová M; Vanícek J; Krupa P; Stanícek J; Koukalová R; Neubauer J; Krivanová A; Mayer J; Hájek R
Vnitr Lek; 2010 Feb; 56(2):138-48. PubMed ID: 20329585
[TBL] [Abstract][Full Text] [Related]
12. Isolated Langerhans cell histiocytosis of the infundibulum presenting with fulminant diabetes insipidus.
Horn EM; Coons SW; Spetzler RF; Rekate HL
Childs Nerv Syst; 2006 May; 22(5):542-4. PubMed ID: 16456689
[TBL] [Abstract][Full Text] [Related]
13. Intensification of induction therapy and prolongation of maintenance therapy did not improve the outcome of pediatric Langerhans cell histiocytosis with single-system multifocal bone lesions: results of the Japan Langerhans Cell Histiocytosis Study Group-02 Protocol Study.
Morimoto A; Shioda Y; Imamura T; Kudo K; Kitoh T; Kawaguchi H; Goto H; Kosaka Y; Tsunematsu Y; Imashuku S;
Int J Hematol; 2018 Aug; 108(2):192-198. PubMed ID: 29594922
[TBL] [Abstract][Full Text] [Related]
14. Diabetes insipidus for five years preceding the diagnosis of hypothalamic Langerhans cell histiocytosis.
Catalina PF; Rodr'iguez Garc'ia M; de la Torre C; P'aramo C; Garc'ia-Mayor RV
J Endocrinol Invest; 1995 Sep; 18(8):663-6. PubMed ID: 8655927
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological features and BRAF
Huo Z; Lu T; Liang Z; Ping F; Shen J; Lu J; Ma W; Zhao D; Zhong D
Diagn Pathol; 2016 Oct; 11(1):100. PubMed ID: 27760550
[TBL] [Abstract][Full Text] [Related]
16. [Hypothalamic-infundibular histiocytosis: magnetic resonance findings].
Crespo-Rodríguez AM; Franco C; Lidón MC; Izquierdo B; Angulo E; Mazas-Artasona LV
Rev Neurol; 2004 Jul 16-31; 39(2):125-9. PubMed ID: 15264161
[TBL] [Abstract][Full Text] [Related]
17. Radiation therapy in patients with histiocytosis: management of diabetes insipidus and bone lesions.
Greenberger JS; Cassady JR; Jaffe N; Vawter G; Crocker AC
Int J Radiat Oncol Biol Phys; 1979 Oct; 5(10):1749-55. PubMed ID: 316811
[No Abstract] [Full Text] [Related]
18. Thickened pituitary stalk on magnetic resonance imaging in children with central diabetes insipidus.
Leger J; Velasquez A; Garel C; Hassan M; Czernichow P
J Clin Endocrinol Metab; 1999 Jun; 84(6):1954-60. PubMed ID: 10372693
[TBL] [Abstract][Full Text] [Related]
19. Pituitary stalk thickening with diabetes insipidus preceding typical manifestations of Langerhans cell histiocytosis in children.
Schmitt S; Wichmann W; Martin E; Zachmann M; Schoenle EJ
Eur J Pediatr; 1993 May; 152(5):399-401. PubMed ID: 8319704
[TBL] [Abstract][Full Text] [Related]
20. [A disseminated form of Langerhans histiocytosis associated with diabetes insipidus and diabetes mellitus].
Ben Ghorbel I; Houman MH; B'chir S; Chamakhi S; Miled M
Rev Med Interne; 2001 May; 22(5):469-74. PubMed ID: 11402519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
